Erratum: Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience.
null null
Published in: Frontiers in endocrinology (2024)
[This corrects the article DOI: 10.3389/fendo.2023.1270421.].